Houston-based TYBR Health, a medtech and orthopedic regenerative medicine company, has secured $30 million in a Series A financing round. The company will use the funds to expand commercial access to its FDA-approved B3 GEL System, broaden its product indications…
Biologics
Vector Science & Therapeutics, a medical technology and therapeutic delivery company, plans to build a dedicated distributor network to commercialize its peptide portfolio across the orthopedic, sports and regenerative medicine markets. The network will target orthopedic and sports medicine practices,…
Ortho Las Vegas has opened a new orthopedic center in Southwest Las Vegas, expanding its surgical, sports medicine and regenerative medicine services in a larger facility. The practice’s new location offers on-site imaging, additional exam and procedure rooms and provides…
A stem cell therapy designed to repair damaged nerve pathways is moving closer to clinical testing for people with chronic spinal cord injury, according to a July 13 Inside Precision Medicine report on research presented at the International Society for…
Here are six new spine and orthopedic biologics that have launched, earned FDA approval or received additional clearances, as reported by Becker’s in the first half of 2026. Note: This list is not exhaustive.
Advertisement
A company-published meta-analysis found allogeneic umbilical cord-derived stem cell therapy was associated with lower knee osteoarthritis pain scores at 12 months than corticosteroid and hyaluronic acid injections, the current non-surgical standard. Longevity Medical Institute published the peer-reviewed review July 6…
Biologics remain one of the most active corners of spine and orthopedics, with new bone graft clearances, distribution deals and pipeline milestones landing across 2026. Here are recent developments worth tracking.
Ventris Medical received more patent coverage for its Backpack system, according to a May 27 news release. The patent strengthens the company’s intellectual property for the Backpack bone graft containment system, which is designed to support spinal fusions. It a…
Atreon Orthopedics and RenovoDerm have merged, according to a May 19 news release. Together the companies will leverage a comprehensive platform of synthetic biomaterial products, expanded clinical indications across orthopedic care and unified Autobiologic technology. “This merger accelerates our ability to…
Miach Orthopaedics named Jamal Rushdy as its new CEO, according to a May 11 news release. Mr. Rushdy replaces Patrick McBrayer following a planned leadership transition in partnership with the board of directors. Mr. Rushdy has nearly 30 years of…